| Follow Us: Facebook Twitter Youtube RSS Feed


Minneapolis biotech leader Techne sees China sales grow 22 percent

The "jewel of the crown" of Minnesota biotechnology wants a prominent place in China's growing biotech economy, too.

The Star Tribune reports that Techne, a Minneapolis biotech and hematology company, is seeing results from its recent expansion into China, despite challenges from knock-offs and counterfeits:

"Less than a year after its Shanghai division began operations in fiscal 2008, it made its first profit and sales grew nearly 22 percent, delivering the largest double-digit sales growth in Techne's biotech division in its last fiscal year," writes Star Tribune reporter Wendy Lee.

Techne, a growing company with 726 employees, creates proteins that are used in medicine and research, including in the development of drugs for cancer and AIDS.
Signup for Email Alerts
Signup for Email Alerts

Related Content